 Company Information |
Listed in:
Research & Development in the Physical, Engineering & Life Sciences
Pharmaceutical & Medicine Manufacturing
Medical Equipment & Supplies Manufacturing
Description:
ProMetic Life Sciences Inc. (TSX-PLI.SV) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Enabling Technology. Mimetic LigandTM technology is used in large-scale purification of biologics and the elimination of pathogens/viruses. ProMetic is also active in Therapeutic Drug Development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of inflammation and cancer. The Companys Mimetic LigandTM technology is also leveraged into its drug discovery platform aiming at replacing complex, expensive proteins with synthetic drug-like protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D and manufacturing facilities in the UK and business development activities in the US, Europe, Asia and MENA countries (Middle East and North Africa).
|
| Products |
 |
Combinational Chemistry
|
|
| |
Solid Phase Screening
|
|
| |
Agaroes And Perfluorocarbon Beads Technology
|
|
| |
Extracorporeal Medical Devices To Remove Therapeutics And Biocon
|
|
| |
Diagnostic Kits
|
|
| |
Drug Delivery System For Proteomics, Genomics And Other Therapeu
|
|
|
 |
|